D H Kim1, J-H Kim2, S H Choi3, C-H Sohn3, T J Yun3, C H Kim4, K-H Chang5. 1. Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea. 2. Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea; The Institute of Radiation Medicine, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: jihnkim@gmail.com. 3. Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea; The Institute of Radiation Medicine, Seoul National University Hospital, Seoul, Republic of Korea. 4. Department of Neurosurgery, Seoul National University, Seoul, Republic of Korea. 5. Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea; Department of Radiology, Soonchunhyang University Bucheon Hospital, Seoul, Republic of Korea.
Abstract
AIM: To investigate magnetic resonance imaging (MRI) findings that could be used to differentiate intramedullary spinal ependymoma from astrocytoma, and to determine predictors for this differentiation. MATERIALS AND METHODS: MRI images of 43 consecutive patients with pathologically proven intramedullary spinal ependymoma (n = 24) and astrocytoma (n = 19) were comparatively evaluated with regard to size, location, margin, signal intensity, contrast enhancement, presence of syringohydromyelia, tumoural cyst, non-tumoural cyst, and haemorrhage. MRI findings and demographic data were compared between the two tumour groups using univariate and multivariate logistic regression analyses. RESULTS: In patients with ependymoma, older age and a larger solid component were more often observed than in astrocytoma. Central location, presence of enhancement, diffuse enhancement, syringohydromyelia, haemorrhage, and cap sign were more frequently observed in ependymoma. However, multivariate analysis revealed that syringohydromyelia was the only variable able to independently differentiate ependymoma from astrocytoma, with an odds ratio of 62.9 (95% CI: 4.38-903.22; p = 0.002). CONCLUSION: Among the various findings, the presence of syringohydromyelia is the main factor distinguishing ependymoma from astrocytoma.
AIM: To investigate magnetic resonance imaging (MRI) findings that could be used to differentiate intramedullary spinal ependymoma from astrocytoma, and to determine predictors for this differentiation. MATERIALS AND METHODS: MRI images of 43 consecutive patients with pathologically proven intramedullary spinal ependymoma (n = 24) and astrocytoma (n = 19) were comparatively evaluated with regard to size, location, margin, signal intensity, contrast enhancement, presence of syringohydromyelia, tumoural cyst, non-tumoural cyst, and haemorrhage. MRI findings and demographic data were compared between the two tumour groups using univariate and multivariate logistic regression analyses. RESULTS: In patients with ependymoma, older age and a larger solid component were more often observed than in astrocytoma. Central location, presence of enhancement, diffuse enhancement, syringohydromyelia, haemorrhage, and cap sign were more frequently observed in ependymoma. However, multivariate analysis revealed that syringohydromyelia was the only variable able to independently differentiate ependymoma from astrocytoma, with an odds ratio of 62.9 (95% CI: 4.38-903.22; p = 0.002). CONCLUSION: Among the various findings, the presence of syringohydromyelia is the main factor distinguishing ependymoma from astrocytoma.
Authors: Vincent Jecko; Paul Roblot; Lorenzo Mongardi; Morgan Ollivier; Natalia Delgado Piccoli; Thomas Charleux; Thomas Wavasseur; Edouard Gimbert; Dominique Liguoro; Guillaume Chotard; Jean-Rodolphe Vignes Journal: Neurospine Date: 2022-03-31
Authors: Zhenxing Sun; Dan Yuan; Yaxing Sun; Yi Guo; Guoqin Wang; Peihai Zhang; James Wang; Wei Shi; Guihuai Wang Journal: J Int Med Res Date: 2022-03 Impact factor: 1.671
Authors: Edyta Maj; Barbara Szemplińska; Wojciech Szeszkowski; Marek Prokopienko; Andrzej Cieszanowski; Andrzej Marchel; Olgierd Rowiński Journal: Clin Neuroradiol Date: 2019-11-21 Impact factor: 3.649